Table 7.
Survival and combination of CD34 and tumour invasion in patients with NSCLC
Groups | Median survival (months) | 95% CI | p Value |
A (CD34+/TVI+) | 15 | 7 to 23 | <0.0001 |
B (CD34−/TVI+, CD34+/TVI−) | 44 | 6 to 82 | |
C (CD34−/TVI−) | 116 | 84 to 148 |
CI, confidence interval; NSCLC, non-small cell lung cancer; TVI, tumour vessel invasion.